Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Welch Allyn Inc.

Division of Hill-Rom Holdings Inc.
www.welchallyn.com

Latest From Boryung Pharmaceuticals Co. Ltd.

Deal Watch: Takeda Seeks A Crescendo With Collaboration On New Type Of Cancer Compound

AstraZeneca concludes week of four out-licensing transactions by selling US rights to Toprol XL to Aralez and ex-US rights to Rhinocort Aqua to J&J. Molecular Partners gets back rights to an IL-13/IL-17 inhibitor for pulmonary indications after a 2011 deal with Janssen unravels.

Deals M & A

Orphan Drugs Korean Pharmas’ Ticket To Global Success?

Amid limited resources and marketing capabilities, South Korean pharmas are increasingly opting for improved and orphan drugs as their ticket to major global markets. Several companies shared their varying strategies for international success during a recent symposium in Seoul.

BioPharmaceutical Asia Pacific

Korean Pharmas Urged To Focus On Emerging Market Exports

Despite the South Korean pharma industry’s strong efforts to boost exports amid a challenging domestic environment, a domestic research report says the industry still lacks competitiveness in the global market and advises pharma firms to focus more on exports to emerging nations which have high growth potential.

BioPharmaceutical South Korea

Korea Clinical Trials Climb As Pharmas Focus On R&D

The number of clinical trials conducted in South Korea has continued to climb on the back of domestic pharma firms’ efforts to transform themselves into R&D-focused companies and the government’s drive to nurture the biopharma industry.

BioPharmaceutical South Korea
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register